Multifactorial Determinants of Functional Capacity in Peripheral Arterial Disease. Uncoupling of Calf Muscle Perfusion and Metabolism

Journal of the American College of Cardiology

Volumn 54, Issue 7, 2009, Pages 628-635

  Anderson, Justin D ^a   Epstein, Frederick H ^b,c   Meyer, Craig H ^b,c   Hagspiel, Klaus D ^a,b   Wang, Hongkun ^d   Berr, Stuart S ^b,c   Harthun, Nancy L ^a   Weltman, Arthur ^a   DiMaria, Joseph M ^b   West, Amy M ^a   Kramer, Christopher M ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c University of Virginia   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

atherosclerosis; blood flow; magnetic resonance imaging; peripheral vascular disease; spectroscopy

Indexed keywords

CREATINE PHOSPHATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; GASTROCNEMIUS MUSCLE; HUMAN; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MUSCLE METABOLISM; MUSCLE PERFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STENOSIS; SUPERFICIAL FEMORAL ARTERY; TISSUE PERFUSION; TREADMILL EXERCISE; WALKING;

ADULT; AGED; EXERCISE TEST; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PERIPHERAL VASCULAR DISEASES; PHOSPHOCREATINE; REGIONAL BLOOD FLOW;

EID: 67849083492     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.01.080     Document Type: Article

References (34)

1. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Golomb B.A., Dang T.T., and Criqui M.H. Peripheral arterial disease: morbidity and mortality implications. Circulation 114 (2006) 688-699
3. Drummond M. Socioeconomic impact of peripheral vascular disease. Atherosclerosis 131 (1997) S33-S34
4. McDermott M.M., Liu K., Greenland P., et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 292 (2004) 453-461
5. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
6. Stewart K.J., Hiatt W.R., Regensteiner J.G., and Hirsch A.T. Exercise training for claudication. N Engl J Med 347 (2002) 1941-1951
7. Labs K.H., Dormandy J.A., Jaeger K.A., Stuerzebecher C.S., and Hiatt W.R. Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: Clinical Trial Methodology. Circulation 100 (1999) e75-e81
8. Isbell D.C., Meyer C.H., Rogers Jr. W.J., et al. Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with magnetic resonance imaging. J Cardiovasc Magn Reson 9 (2007) 71-76
9. Isbell D.C., Epstein F.H., Zhong X., et al. Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first pass contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 25 (2007) 1013-1020
10. Isbell D.C., Berr S.S., Toledano A.Y., et al. Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol 47 (2006) 2289-2297
11. Saam T., Kerwin W.S., Chu B., et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 7 (2005) 799-808
12. Ouwendijk R., de Vries M., Pattynama P.M.T., et al. Imaging peripheral arterial disease: a randomized controlled trial comparing contrast-enhanced MR angiography and multi-detector row CT angiography. Radiology 236 (2005) 1094-1103
13. Peterkin G.A., Manabe S., LaMorte W.W., and Menzoian J.O. Evaluation of a proposed standard reporting system for preoperative angiograms in infrainguinal bypass procedures: angiographic correlates of measured runoff resistance. J Vasc Surg 7 (1988) 379-385
14. Gardner A.W., Skinner J.S., Cantwell B.W., and Smith L.K. Progressive vs. single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc 23 (1991) 402-408
15. Kohl H.W., Blair S.N., Paffenbarger R.S., Macera C.A., and Kronefeld J.J. A mail survey of physical activity habits as related to measured physical fitness. Am J Epidemiol 127 (1988) 1228-1239
16. Ainsworth B.E., Haskell W.L., Whitt M.C., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32 (2000) S498-S516
17. Bourque J.M., Schietinger B.J., Kennedy J.L., et al. A novel approach for screening atherosclerosis in diabetes: MRI of the superficial femoral artery (abstr). J Cardiovasc Magn Reson 10 (2008) 401A
18. Atkins L.M., and Gardner A.W. The relationship between lower extremity functional strength and severity of peripheral arterial disease. Angiology 55 (2004) 347-355
19. Szuba A., Oka R.K., Harada R., and Cooke J.P. Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med 11 (2006) 155-163
20. Hiatt W.R., Regensteiner J.G., Hargarten M.E., Wolfel E.E., and Brass E.P. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 81 (1990) 602-609
21. Brass E.P., and Hiatt W.R. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med 5 (2000) 55-59
22. Pipinos I.I., Judge A.R., Selsby J.T., et al. The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc Endovascular Surg 41 (2007) 481-489
23. Hiatt W.R., Regensteiner J.G., Wolfel E.E., Carry M.R., and Brass E.P. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol 81 (1996) 780-788
24. Greiner A., Esterhammer R., Messner H., et al. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. J Vasc Surg 43 (2006) 978-986
25. Pipinos I.I., Boska M.D., Shepard A.D., Anagnostopoulos P.V., and Katsamouris A. Pentoxifylline reverses oxidative mitochondrial defect in claudicating skeletal muscle. J Surg Res 102 (2002) 126-132
26. Hiatt W.R., Cox L., Greenwalt M., Griffin A., and Schechter C. Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials. Vasc Med 10 (2005) 207-213
27. McDermott M.M., Tian L., Liu K., et al. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol 51 (2008) 1482-1489
28. Baumgartner I., Thoeny H.C., Kummer O., et al. Leg ischemia: assessment with MR angiography and spectroscopy. Radiology 234 (2005) 833-841
29. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
30. Ix J.H., Allison M.A., Denenberg J.O., Cushman M., and Criqui M.H. Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population study. J Am Coll Cardiol 51 (2008) 2347-2354
31. McDermott M.M., Greenland P., Green D., et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 107 (2003) 3191-3198
32. Brevetti G., Silvestro A., Schiano V., and Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108 (2003) 2093-2098
33. Food and Drug Administration. Information on Gadolinium-Containing Contrast Agents. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm142882.htm Accessed June 19, 2009
34. Prince M.R., Zhang H., Morris M., et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248 (2008) 807-816